Assessment and Concordance of Serum Anti JC Virus Antibodies and JCV DNA Presence in Multiple Sclerosis Natalizumab Treated Patients

被引：0
|
作者：
Lanzillo, Roberta [1 ]
Vallefuoco, Luca [1 ]
Liuzzi, Raffaele [2 ]
Guacci, Anna [1 ]
Amato, Luca [1 ]
Vacca, Giovanni [1 ]
Orefice, Giuseppe [1 ]
Portella, Giuseppe [1 ]
Morra, Vincenzo Brescia [3 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] CNR, Naples, Italy
[3] Univ Naples Federico II, Salerno, Italy
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P07054
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CONTRIBUTION OF NATALIZUMAB EXPOSURE, PRIOR IMMUNOSUPPRESSANT (IS) USE, AND JC VIRUS (JCV) INFECTION TO PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) RISK IN NATALIZUMAB-TREATED MULTIPLE SCLEROSIS (MS) PATIENTS
    Bloomgren, G.
    Richman, S.
    Goelz, S.
    Hotermans, C.
    Hyde, R.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Subramanyam, M.
    Sandrock, A. W.
    Bozic, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 60 - 60
  • [42] Evaluation of natalizumab treatment on the presence of JC virus in blood and urine from multiple sclerosis patients
    Rudick, R. A.
    Polman, C. H.
    O'Connor, P. W.
    Goodman, A.
    Ray, S.
    Ryschkewitsch, C.
    Jurgensen, S.
    Goelz, S.
    Forrestal, F.
    Gorelik, L.
    Panzara, M. A.
    Sandrock, A. W.
    Major, E. O.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S274 - S275
  • [43] Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients
    Anat Achiron
    Gadi Miron
    Rina Zilkha-Falb
    David Magalashvili
    Mark Dolev
    Yael Stern
    Michael Gurevich
    Journal of NeuroVirology, 2016, 22 : 736 - 746
  • [44] Evaluation of the Incidence of Anti-JC Virus Antibodies in a Cohort of Natalizumab-Treated Patients
    Pepio, Anthony M.
    Mocci, Simonetta
    Taylor, Julie
    Taylor, Lori
    Yednock, Ted
    Gorelik, Leonid
    Goelz, Susan
    Subramanyam, Meena
    GASTROENTEROLOGY, 2010, 138 (05) : S146 - S146
  • [45] Evaluation of the Incidence of Anti-JC Virus Antibodies in a Cohort of Natalizumab-Treated Patients
    Pepio, Anthony M.
    Taylor, Lori
    Jams, Mark
    Mocci, Simonetta
    Yednock, Ted
    Hogge, Gary S.
    Plavina, Tatiana
    Gorelik, Leonid
    Goetz, Susan E.
    Natarajan, Amy
    Lee, Sophia
    Richman, Sandra
    Subramanyam, Meena
    GASTROENTEROLOGY, 2011, 140 (05) : S768 - S768
  • [46] Anti-Natalizumab Antibodies in Patients with Multiple Sclerosis
    Lundkvist, Malin
    Engdahl, Elin
    Holmen, Carolina
    Moverare, Robert
    Olsson, Tomas
    Hillert, Jan
    Fogdell-Hahn, Anna
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 76 (02) : 206 - 207
  • [47] Assessment of JC Virus DNA in Blood and Urine from Natalizumab-Treated Patients
    Rudick, Richard A.
    O'Connor, Paul W.
    Polman, Chris H.
    Goodman, Andrew D.
    Ray, Soma S.
    Griffith, Nancy M.
    Jurgensen, Stephanie A.
    Gorelik, Leonid
    Forrestal, Fiona
    Sandrock, Alfred W.
    Goelz, Susan E.
    ANNALS OF NEUROLOGY, 2010, 68 (03) : 304 - 310
  • [48] Assessment of JC Virus DNA in Blood and Urine from Natalizumab-Treated Patients
    Warnke, Clemens
    Adams, Ortwin
    Hartung, Hans-Peter
    Kieseier, Bernd C.
    ANNALS OF NEUROLOGY, 2011, 69 (01) : 215 - 216
  • [49] Evaluation of the Incidence of Anti-JC Virus Antibodies in a Cohort of Natalizumab-Treated Patients
    Pepio, Anthony
    Taylor, Lori
    Jaros, Mark
    Mocci, Simonetta
    Taylor, Julie
    Yednock, Ted
    Plavina, Tatiana
    Gorelik, Leonid
    Goelz, Susan
    Subramanyam, Meena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S432 - S432
  • [50] JC Virus Persistence Following Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated with Natalizumab
    Ryschkewitsch, Caroline F.
    Jensen, Peter N.
    Monaco, Maria Chiara
    Major, Eugene O.
    ANNALS OF NEUROLOGY, 2010, 68 (03) : 384 - 391
12345